Does the Choice of Chemotherapeutic Agent, Mitomycin C vs Oxaliplatin, Matter in Cytoreductive Surgery and Hyperthemic Intraperitoneal Chemotherapy? Irada Ibrahim-Zada, MD, PhD, Camille Stewart, Rodrigo Asturias Luna, Alyssa Blood, Csaba Gajdos, MD, FACS, Barish Edil, Nathan Pearlman, MD, Ana Gleisner, MD, PhD, Martin D. McCarter, MD, FACS Journal of the American College of Surgeons Volume 225, Issue 4, Pages S190-S191 (October 2017) DOI: 10.1016/j.jamcollsurg.2017.07.434 Copyright © 2017 Terms and Conditions
Journal of the American College of Surgeons 2017 225, S190-S191DOI: (10.1016/j.jamcollsurg.2017.07.434) Copyright © 2017 Terms and Conditions